Study List


Study List

Clinical Studies

NCT Number Gene Therapy Sponsor Status Brief Title Phase View
NCT00004451 Positive Gene Therapy National Institute of Mental Health (NIMH) COMPLETED Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease Patients NA View
NCT00004450 FDA Office of Orphan Products Development COMPLETED Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy NA View
NCT00004433 Positive Gene Therapy Children's Hospital Medical Center, Cincinnati COMPLETED Randomized Study of Pergolide in Children With Tourette Syndrome NA View
NCT00004428 FDA Office of Orphan Products Development COMPLETED Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic Fibrosis PHASE1 View
NCT00004420 FDA Office of Orphan Products Development COMPLETED Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis NA View
NCT00004418 Hugo W. Moser Research Institute at Kennedy Krieger, Inc. TERMINATED Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy PHASE2 View
NCT00004412 Positive Gene Therapy Susan P. Perrine COMPLETED Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers PHASE2 View
NCT00004408 Mast Therapeutics, Inc. COMPLETED Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease PHASE3 View
NCT00004404 Boston Children's Hospital COMPLETED Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes NA View
NCT00004403 Johns Hopkins University COMPLETED Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis NA View
NCT00004402 FDA Office of Orphan Products Development COMPLETED Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis PHASE3 View
NCT00004393 National Center for Research Resources (NCRR) COMPLETED Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome PHASE2 View
NCT00004392 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) COMPLETED Incidence and Severity of Cardiorespiratory Events in Infants at Increased Epidemiological Risk for Sudden Infant Death Syndrome (SIDS) View
NCT00004368 National Center for Research Resources (NCRR) UNKNOWN Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis PHASE1 View
NCT00004367 National Center for Research Resources (NCRR) COMPLETED Vestibular Dysfunction In Adult Patients With Panic Disorder With or Without Agoraphobia NA View
NCT00004366 National Center for Research Resources (NCRR) COMPLETED Pilot Study of Vestibular Rehabilitation Training for Panic Disorder With Vestibular Dysfunction NA View
NCT00004361 National Center for Research Resources (NCRR) COMPLETED Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects View
NCT00004360 National Center for Research Resources (NCRR) COMPLETED Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus View
NCT00004359 National Center for Research Resources (NCRR) COMPLETED Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita PHASE2 View
NCT00004358 National Center for Research Resources (NCRR) COMPLETED Phase II Study of Calcitonin for Tumoral Calcinosis PHASE2 View
NCT00004357 Positive Gene Therapy Northwestern University COMPLETED Absorption of Corticosteroids in Children With Juvenile Dermatomyositis PHASE2 View
NCT00004356 National Center for Research Resources (NCRR) COMPLETED Study of Homocysteine Metabolism in Homocystinuria View
NCT00004351 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes View
NCT00004350 National Center for Research Resources (NCRR) COMPLETED Evaluation of Fanconi Syndrome and Cystinosis View
NCT00004335 National Center for Research Resources (NCRR) COMPLETED Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the Menstrual Cycle View
NCT00004334 Positive Gene Therapy National Center for Research Resources (NCRR) UNKNOWN Study of Depression, Peptides, and Steroids in Cushing's Syndrome View
NCT00004333 National Center for Research Resources (NCRR) COMPLETED Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type I PHASE2 View
NCT00004332 National Center for Research Resources (NCRR) COMPLETED Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly View
NCT00004327 National Center for Research Resources (NCRR) COMPLETED Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia PHASE2 View
NCT00004306 Positive Gene Therapy Office of Rare Diseases (ORD) COMPLETED Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10) View
NCT00004305 National Center for Research Resources (NCRR) COMPLETED Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis View
NCT00004294 National Center for Research Resources (NCRR) COMPLETED Phase I Study of Retrovirally Mediated Transfer of the Human Glucocerebrosidase Gene Into Peripheral Blood Stem Cells for Autologous Transplantation in Patients With Type I Gaucher Disease PHASE1 View
NCT00004293 National Center for Research Resources (NCRR) UNKNOWN Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease PHASE2 View
NCT00004268 National Center for Research Resources (NCRR) COMPLETED Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension PHASE2 View
NCT00004266 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) COMPLETED Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes PHASE3 View
NCT00004261 University Health Network, Toronto TERMINATED EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma PHASE1 View
NCT00004260 Mayo Clinic COMPLETED Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma PHASE1 View
NCT00004259 Radiation Therapy Oncology Group COMPLETED Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas PHASE3 View
NCT00004258 Indiana University School of Medicine COMPLETED EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer PHASE1 View
NCT00004257 Albany Medical College COMPLETED Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer PHASE1 View
NCT00004256 Royal Marsden NHS Foundation Trust COMPLETED Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer PHASE2 View
NCT00004251 NCIC Clinical Trials Group COMPLETED Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer PHASE2 View
NCT00004250 Memorial Sloan Kettering Cancer Center COMPLETED Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery PHASE2 View
NCT00004235 Alliance for Clinical Trials in Oncology COMPLETED Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach PHASE2 View
NCT00004234 NCIC Clinical Trials Group COMPLETED Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx PHASE3 View
NCT00004233 SWOG Cancer Research Network COMPLETED S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach PHASE2 View
NCT00004232 Northwestern University COMPLETED Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer PHASE1 View
NCT00004220 City of Hope Medical Center COMPLETED Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer PHASE1 View
NCT00004218 Leukemia Research Fund COMPLETED Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia PHASE3 View
NCT00004205 ETOP IBCSG Partners Foundation COMPLETED Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer PHASE3 View
NCT00004204 Herbert Irving Comprehensive Cancer Center UNKNOWN Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma PHASE2 View
NCT00004203 University of Chicago COMPLETED Oxaliplatin in Treating Patients With Metastatic Bladder Cancer PHASE2 View
NCT00004202 Spectrum Pharmaceuticals, Inc COMPLETED Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer PHASE2 View
NCT00004195 University of Alabama at Birmingham COMPLETED Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer PHASE2 View
NCT00004194 Jonsson Comprehensive Cancer Center UNKNOWN Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease PHASE1 View
NCT00004193 Positive Gene Therapy University of Alabama at Birmingham TERMINATED ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer PHASE2 View
NCT00004192 University of Nebraska COMPLETED Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma PHASE2 View
NCT00004169 Northwestern University COMPLETED Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease PHASE2 View
NCT00004166 Northwestern University COMPLETED Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy PHASE3 View
NCT00004161 Positive Gene Therapy University of Alabama at Birmingham COMPLETED Fenretinide in Treating Patients With Leukoplakia of the Mouth PHASE2 View
NCT00004160 University of Alabama at Birmingham COMPLETED Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed PHASE1 View
NCT00004159 University of Alabama at Birmingham TERMINATED Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor PHASE1 View
NCT00004158 Fred Hutchinson Cancer Center COMPLETED Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma PHASE1 View
NCT00004157 Fred Hutchinson Cancer Center COMPLETED Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors PHASE2 View
NCT00004156 Memorial Sloan Kettering Cancer Center COMPLETED Vaccine Therapy in Treating Patients With Breast Cancer PHASE1 View
NCT00004151 Positive Gene Therapy European Organisation for Research and Treatment of Cancer - EORTC COMPLETED Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer PHASE2 View
NCT00004150 Robert Roessle Klinik COMPLETED High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer PHASE3 View
NCT00004135 University of Chicago COMPLETED Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer PHASE2 View
NCT00004132 Jonsson Comprehensive Cancer Center COMPLETED Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer PHASE2 View
NCT00004127 University of Chicago COMPLETED Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach PHASE2 View
NCT00004106 Northwestern University TERMINATED Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome PHASE2 View
NCT00004105 NYU Langone Health COMPLETED Combination Chemotherapy in Treating Patients With Advanced Cancer PHASE1 View
NCT00004104 NYU Langone Health COMPLETED Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma PHASE2 View
NCT00004103 NYU Langone Health COMPLETED Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer PHASE2 View
NCT00004102 NYU Langone Health COMPLETED Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer PHASE2 View
NCT00004095 Northwestern University COMPLETED Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors PHASE1 View
NCT00004094 National Cancer Institute (NCI) UNKNOWN Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx PHASE2 View
NCT00004093 Northwestern University TERMINATED Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer PHASE1 View
NCT00004092 City of Hope Medical Center COMPLETED Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer PHASE2 View
NCT00004068 St. Jude Children's Research Hospital COMPLETED Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor PHASE2 View
NCT00004067 NSABP Foundation Inc COMPLETED Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 PHASE3 View
NCT00004066 Memorial Sloan Kettering Cancer Center COMPLETED Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma PHASE2 View
NCT00004061 Memorial Sloan Kettering Cancer Center COMPLETED Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer PHASE2 View
NCT00004060 Daiichi Sankyo COMPLETED Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer PHASE2 View
NCT00004059 Memorial Sloan Kettering Cancer Center COMPLETED Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors PHASE1 View
NCT00004058 University of Medicine and Dentistry of New Jersey TERMINATED 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder PHASE1 View
NCT00004057 Positive Gene Therapy Memorial Sloan Kettering Cancer Center COMPLETED Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas PHASE1 View
NCT00004056 Children's Oncology Group COMPLETED Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia PHASE1 View
NCT00004051 Memorial Sloan Kettering Cancer Center COMPLETED Irinotecan in Treating Patients With Advanced Solid Tumors PHASE1 View
NCT00004050 Positive Gene Therapy Vical TERMINATED Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer PHASE2 View
NCT00004033 Positive Gene Therapy NYU Langone Health COMPLETED Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma PHASE2 View
NCT00004032 National Cancer Institute (NCI) COMPLETED Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer PHASE1 View
NCT00004005 St. Jude Children's Research Hospital COMPLETED Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin PHASE2 View
NCT00004004 New Approaches to Brain Tumor Therapy Consortium COMPLETED Procarbazine in Treating Patients With Recurrent Brain Tumor PHASE1 View
NCT00004003 Barbara Ann Karmanos Cancer Institute COMPLETED Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery PHASE2 View
NCT00004002 NYU Langone Health COMPLETED PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma PHASE1 View
NCT00003995 National Cancer Institute (NCI) COMPLETED Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2 PHASE2 View
NCT00003994 Children's Oncology Group COMPLETED Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer PHASE3 View
NCT00003993 National Institute on Aging (NIA) COMPLETED Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma PHASE1 View
NCT00003992 National Cancer Institute (NCI) COMPLETED Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2 PHASE2 View
NCT00003969 Cancer Research UK COMPLETED Geldanamycin Analogue in Treating Patients With Advanced Cancer PHASE1 View
NCT00003968 Positive Gene Therapy National Cancer Institute (NCI) COMPLETED Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer PHASE2 View
NCT00003967 Gynecologic Oncology Group COMPLETED Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer PHASE1 View
NCT00003966 Dana-Farber Cancer Institute COMPLETED Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation PHASE2 View
NCT00003961 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins COMPLETED Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome PHASE2 View
NCT00003960 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins COMPLETED Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer PHASE2 View
NCT00003959 Memorial Sloan Kettering Cancer Center COMPLETED Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome PHASE1 View
NCT00003958 Children's Oncology Group COMPLETED Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma PHASE3 View
NCT00003957 Fox Chase Cancer Center COMPLETED Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma PHASE2 View
NCT00003956 Memorial Sloan Kettering Cancer Center COMPLETED Combination Chemotherapy in Treating Patients With Advanced Cancer PHASE1 View
NCT00003951 Daiichi Sankyo COMPLETED DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas PHASE2 View
NCT00003950 Positive Gene Therapy University of Chicago COMPLETED Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer PHASE2 View
NCT00003935 Children's Oncology Group COMPLETED Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma PHASE1 View
NCT00003934 National Cancer Institute (NCI) COMPLETED Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia PHASE3 View
NCT00003933 Positive Gene Therapy Children's Oncology Group COMPLETED Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia NA View
NCT00003928 Positive Gene Therapy Case Comprehensive Cancer Center COMPLETED Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer PHASE2 View
NCT00003920 University of California, Davis UNKNOWN Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer PHASE1 View
NCT00003912 Positive Gene Therapy Societe Internationale d'Oncologie Pediatrique COMPLETED Chemotherapy in Treating Children With Liver Cancer PHASE3 View
NCT00003908 SWOG Cancer Research Network COMPLETED S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer PHASE2 View
NCT00003903 University of Rochester COMPLETED Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer NA View
NCT00003902 Swiss Cancer Institute COMPLETED Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement PHASE1 View
NCT00003895 National Cancer Institute (NCI) COMPLETED Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma PHASE2 View
NCT00003894 Roswell Park Cancer Institute COMPLETED Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant PHASE2 View
NCT00003893 University Hospital Birmingham COMPLETED Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer PHASE3 View
NCT00003892 NCIC Clinical Trials Group COMPLETED ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer PHASE2 View
NCT00003869 National Cancer Institute (NCI) COMPLETED Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer PHASE3 View
NCT00003868 Fred Hutchinson Cancer Center COMPLETED Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia PHASE2 View
NCT00003867 Montefiore Medical Center COMPLETED Irinotecan and Capecitabine in Treating Patients With Solid Tumors PHASE1 View
NCT00003861 Alliance for Clinical Trials in Oncology ACTIVE_NOT_RECRUITING Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia View
NCT00003860 UNICANCER COMPLETED Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer PHASE2 View
NCT00003859 Societe Internationale d'Oncologie Pediatrique COMPLETED Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS PHASE3 View
NCT00003858 Alliance for Clinical Trials in Oncology WITHDRAWN Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence PHASE2 View
NCT00003857 Radiation Therapy Oncology Group COMPLETED Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ PHASE3 View
NCT00003856 Quintiles, Inc. UNKNOWN Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy PHASE2 View
NCT00003851 Columbia University TERMINATED Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer NA View
NCT00003850 National Cancer Institute (NCI) COMPLETED Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer PHASE2 View
NCT00003835 National Cancer Institute (NCI) COMPLETED Combination Chemotherapy in Treating Patients With Stage III Colon Cancer PHASE3 View
NCT00003834 Alliance for Clinical Trials in Oncology COMPLETED Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer PHASE2 View
NCT00003833 Positive Gene Therapy Alliance for Clinical Trials in Oncology COMPLETED Genetic Study in Patients With Stage II or Stage III Colon Cancer View
NCT00003832 Positive Gene Therapy National Cancer Institute (NCI) COMPLETED Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer PHASE2 View
NCT00003820 Ranjana Advani COMPLETED Rituximab in Treating Patients With Hodgkin's Lymphoma PHASE2 View
NCT00003816 Roswell Park Cancer Institute COMPLETED Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer PHASE2 View
NCT00003805 European Organisation for Research and Treatment of Cancer - EORTC COMPLETED Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count PHASE3 View
NCT00003804 University of Leicester UNKNOWN Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor PHASE3 View
NCT00003803 Positive Gene Therapy European Organisation for Research and Treatment of Cancer - EORTC TERMINATED Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed PHASE3 View
NCT00003802 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins COMPLETED Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma PHASE2 View
NCT00003800 Eastern Cooperative Oncology Group COMPLETED Diagnostic Study of Patients With Stage I Testicular Cancer NA View
NCT00003795 Gynecologic Oncology Group COMPLETED Quality of Life in Survivors of Gynecologic Cancer View
NCT00003794 Gynecologic Oncology Group TERMINATED Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer View
NCT00003793 Children's Oncology Group COMPLETED Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma View
NCT00003792 Baylor Health Care System COMPLETED Vaccine Therapy in Treating Patients With Metastatic Melanoma PHASE1 View
NCT00003769 Indiana University School of Medicine COMPLETED Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer PHASE2 View
NCT00003768 Case Comprehensive Cancer Center COMPLETED Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors PHASE1 View
NCT00003766 University of Chicago COMPLETED O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be Removed During Surgery PHASE1 View
NCT00003761 Dana-Farber Cancer Institute COMPLETED Vaccine Therapy in Treating Patients With Metastatic Breast Cancer PHASE1 View
NCT00003760 The University of Texas Health Science Center at San Antonio COMPLETED Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer PHASE2 View
NCT00003759 Anthra Pharmaceuticals COMPLETED AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer PHASE2 View
NCT00003758 European Organisation for Research and Treatment of Cancer - EORTC UNKNOWN Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia PHASE2 View
NCT00003757 Swiss Cancer Institute COMPLETED Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy PHASE2 View
NCT00003751 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins COMPLETED Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma PHASE2 View
NCT00003750 Children's Oncology Group COMPLETED Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors PHASE1 View
NCT00003735 Children's Oncology Group COMPLETED Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia PHASE2 View
NCT00003734 Positive Gene Therapy St. Luke's Hospital, Ireland UNKNOWN Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer PHASE3 View
NCT00003733 SmithKline Beecham UNKNOWN Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer PHASE2 View
NCT00003732 Rigshospitalet, Denmark COMPLETED Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer PHASE2 View
NCT00003720 Pfizer COMPLETED SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma PHASE1 View
NCT00003718 Herbert Irving Comprehensive Cancer Center UNKNOWN Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma PHASE2 View
NCT00003712 Positive Gene Therapy The University of Texas Health Science Center at San Antonio COMPLETED CCI-779 in Treating Patients With Advanced Solid Tumors PHASE1 View
NCT00003705 San Antonio Cancer Institute COMPLETED BMS-184476 in Treating Patients With Advanced Solid Tumors PHASE1 View
NCT00003704 Alliance for Clinical Trials in Oncology COMPLETED Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer PHASE1 View
NCT00003703 Jewish General Hospital COMPLETED Chemotherapy in Treating Patients With Advanced Solid Tumors PHASE1 View
NCT00003702 Gynecologic Oncology Group COMPLETED Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia PHASE3 View
NCT00003695 Medical Research Council COMPLETED Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III Ovarian Cancer PHASE3 View
NCT00003694 National Cancer Institute (NCI) COMPLETED Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase PHASE2 View
NCT00003693 M.D. Anderson Cancer Center COMPLETED Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia PHASE1 View
NCT00003692 Alliance for Clinical Trials in Oncology COMPLETED Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer PHASE2 View
NCT00003669 Eli Lilly and Company COMPLETED Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer PHASE2 View
NCT00003667 Memorial Sloan Kettering Cancer Center COMPLETED Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma PHASE2 View
NCT00003666 Alliance for Clinical Trials in Oncology COMPLETED Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer PHASE2 View
NCT00003661 Positive Gene Therapy Roswell Park Cancer Institute COMPLETED Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer PHASE2 View
NCT00003659 Memorial Sloan Kettering Cancer Center COMPLETED Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia PHASE2 View
NCT00003658 Memorial Sloan Kettering Cancer Center COMPLETED Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers PHASE2 View
NCT00003657 Dana-Farber Cancer Institute COMPLETED High-dose ICE With Amifostine PHASE2 View
NCT00003656 Weill Medical College of Cornell University COMPLETED Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer PHASE2 View
NCT00003650 UNICANCER COMPLETED Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma PHASE3 View
NCT00003635 GlaxoSmithKline COMPLETED 506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents PHASE2 View
NCT00003634 Positive Gene Therapy AltaRex UNKNOWN Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy PHASE2 View
NCT00003633 Herbert Irving Comprehensive Cancer Center UNKNOWN Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer PHASE1 View
NCT00003632 Memorial Sloan Kettering Cancer Center COMPLETED Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma PHASE2 View
NCT00003627 UNICANCER COMPLETED Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx PHASE3 View
NCT00003620 National Cancer Institute (NCI) COMPLETED Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia PHASE2 View
NCT00003606 Positive Gene Therapy UNICANCER COMPLETED Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer PHASE3 View
NCT00003605 Hoag Memorial Hospital Presbyterian WITHDRAWN Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma PHASE2 View
NCT00003604 Cancer Biotherapy Research Group UNKNOWN Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery PHASE2 View
NCT00003603 Riverside Haematology Group UNKNOWN Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma PHASE3 View
NCT00003602 Riverside Haematology Group UNKNOWN Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia PHASE3 View
NCT00003595 National Cancer Institute (NCI) COMPLETED Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma PHASE3 View
NCT00003594 Alliance for Clinical Trials in Oncology COMPLETED Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer PHASE3 View
NCT00003593 Children's Oncology Group COMPLETED Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome PHASE3 View
NCT00003592 Positive Gene Therapy Eastern Cooperative Oncology Group COMPLETED Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer PHASE3 View